ENTITY
Shanghai HeartCare Medical Technology

Shanghai HeartCare Medical Technology (6609 HK)

32
Analysis
Health CareChina
Shanghai HeartCare Medical Technology Corporation Limited develops and manufactures neuro-interventional medical devices. The Company produces ischemic stroke prevention devices, ischemic stroke thrombectomy devices, intracranial stenosis treatment devicies, vacular access devices, and more. Shanghai HeartCare Medical Technology conducts business in China.
more
Refresh
02 Feb 2022 09:14

Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns

We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...

Logo
285 Views
Share
06 Jan 2022 09:52

Aequitas 2021 IPOs and Placements Performance Review - Busiest Year on Record

2021 marked our sixth year of Asia ECM coverage. Most markets were in top gear on the ECM front and we ended the year covering the highest number...

Logo
403 Views
Share
30 Dec 2021 09:15

Concerns and Outlook on China Neuro-Interventional Industry

The insight analyzed China neuro-interventional industry including the reason of cool-down in primary market, the product homogenization, fierce...

Logo
497 Views
Share
29 Dec 2021 14:45

Shanghai HeartCare Medcl(6609 HK): Comprehensive Stroke Produce Portfolio Comes with a Pinch of Salt

Comprehensive and innovative product portfolio addressing large patient pool is the key positive for the company. However, ongoing patent...

Logo
325 Views
Share
15 Nov 2021 09:04

China Healthcare Weekly (Nov.12)-Medical Insurance Negotiation,Spring Coil VBP,Valuation Upside Down

This insight mainly analyzed some news circulating about 2021 national medical insurance negotiation results, VBP on spring coil in Hebei and...

Logo
133 Views
Share
x